Defense Daily Network
Login | Subscribe
Advanced Search
Army Navy-USMC Air Force Congress Business Homeland International Space Financial  

May 14, 2008

Emergent BioSolutions Acquires VaxGen's Anthrax Vaccine Technology

Full Issue | Comments | Print | Email | Archives | Copyright Permissions |

Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone...

Username:
Password:
 
Log in Help

Also in this Issue
AUSA
Defense Daily Insider
Article Archives
DoD Budgets
Weapons Spotlight
 Document Drawer
RDDS

Tool Box
Events & Webinars
Media Kit 		Job Center
Publications & Reports
Defense Job Center
FEATURED EMPLOYER
Defense Information System Agency

Post a job listing
Post an Anonymous Resume
View All Jobs
Defense Daily Books
The Perfect Storm: Security Clearance Delays & Aging Workforce Issues in Defense 

Safeguarding Facilities in a Time of Terrorism

Money & the Military

Overcoming the Military Oil Addiction

Combating the IED Challenge

Defense Industry Globalization: The All-American Arsenal of Democracy Disappears
Defense Daily
05:44 PM
Small Asteroid to Light Up Sky Over Africa
05:21 PM
ATK and Elbit Systems Conduct Successful Flight Test of GATR
04:57 PM
Chief of Staff of the Iraqi Joint Forces To Address Security and Defense Issues in the October 16-17 Conference
 
Defense Daily Insider
–
Hill Denies Over $500 Million In Omnibus DoD Reprogrammming, Axes Most New Starts
–
Defense Watch
–
Danzig: Obama Has No Stance On Tanker Battle, Would Level Playing Field
–
Army Releases New Doctrine: FM 3-07 Stability Operations
–
Raytheon Counter-IED TF Forges Ahead--Discovers Disruptive Technologies

Copyright © 2008 Access Intelligence, LLC. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission of Access Intelligence, LLC is prohibited.